肺癌后第二及更高序次吸烟相关原发癌的发病率:基于人群的队列研究
该研究基于英格兰2000至2014年癌症登记数据,分析肺癌幸存者后续吸烟相关原发癌的发病率。结果显示,吸烟相关第二原发癌风险至少持续10年,50岁和79岁初诊者风险尤高,女性标准化发病率比高于男性,且近十年第二原发肺癌发病率翻倍。作者建议对高危人群将常规随访从5年延长至10年,并监测其他吸烟相关癌症。
要点
- 肺癌幸存者后续吸烟相关原发癌风险至少持续10年。
- 初诊年龄50岁和79岁者第二原发癌风险尤高。
- 女性第二原发癌标准化发病率比 consistently 高于男性。
核心结论
- 肺癌幸存者后续肺癌、喉癌、头颈癌和食管鳞癌的发病率至少持续升高十年。
- 应考虑将最高危人群的常规随访从5年延长至10年,并监测其他吸烟相关癌症。
研究设计与样本
- 基于英格兰2000至2014年癌症登记数据的基于人群的队列研究。
- 数据来自Public Health England National Cancer Registration and Analysis Service。
- 使用Poisson回归计算绝对发病率和标准化发病率比,随访至初诊后10年。
主要发现
- 吸烟相关第二原发癌的发病率升高至少持续10年。
- 初诊年龄50岁和79岁者风险尤高。
- 第二原发癌中最常见类型为肺癌。
- 标准化发病率比最高为食管鳞癌(2.4)和喉癌(2.8),女性 consistently 高于男性。
- 近十年第二原发肺癌发病率翻倍。
关键数值与推荐
- 食管鳞癌标准化发病率比2.4。
- 喉癌标准化发病率比2.8。
- 女性标准化发病率比 consistently 高于男性。
- 近十年第二原发肺癌发病率翻倍。
临床怎么用
- 对肺癌幸存者应关注至少10年的第二原发癌风险。
- 对初诊年龄50岁和79岁等高危人群可考虑延长随访至10年。
- 随访中需监测其他吸烟相关癌症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer 5-year survival has doubled over 15 years. Although the risk of second primary cancer is recognised, quantification over time is lacking. We describe the incidence of second and higher order smoking-related primary cancers in lung cancer survivors, identifying high-incidence groups and how incidence changes over time from first diagnosis. METHODS: Data on smoking-related primary cancers (lung, laryngeal, head and neck, oesophageal squamous cell carcinoma and bladder) diagnosed in England between 2000 and 2014 were obtained from Public Health England National Cancer Registration and Analysis Service. We calculated absolute incidence rates and standardised incidence rate ratios, both overall and for various subgroups of second primary cancer for up to 10 years from the initial diagnosis of lung cancer, using Poisson regression. RESULTS: Elevated incidence of smoking-related second primary cancer persists for at least 10 years from first lung cancer diagnosis with those aged 50 and 79 at first diagnosis at particularly high risk. The most frequent type of second malignancy was lung cancer although the highest standardised incidence rate ratios were for oesophageal squamous cell carcinoma (2.4) and laryngeal cancers (2.8) and consistently higher in women than in men. Over the last decade, the incidence of second primary lung cancer has doubled. CONCLUSION: Lung cancer survivors have increased the incidence of subsequent lung, laryngeal, head and neck and oesophageal squamous cell carcinoma for at least a decade from the first diagnosis. Consideration should be given to increasing routine follow-up from 5 years to 10 years for those at highest risk, alongside surveillance for other smoking-related cancers.
引用
- Barclay ME, Lyratzopoulos G, Walter FM, et al. Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study. Thorax. 2019. PMID: 30777897. doi:10.1136/thoraxjnl-2018-212456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。